English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

The carbohydrate antigen 19–9 (CA 19–9), a determinant (sialylated lacto-N-fucopentaose 119) of a circulating oligosaccharide antigen, is a frequently used tumor marker.  Echinococcus  spp. infects humans throughout the world and may be able to synthesize closely related molecules which could interfere with the measurement and interpretation of CA 19–9 concentration. The main objective of the present study was to determine the range of CA 19–9 levels in the sera of patients infected by  E. granulosus  (cystic hydatide disease; CYSHD) or  E. multilocularis  (alveolar hydatide disease; ALVHD).

Elevated Carbohydrate Antigen 19-9 (CA 19-9) in Patients with Echinococcus Infection